Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00807742 · ClinicalTrials.gov registry record · NA

Contingency Management for Smoking in Substance Abusers

A NA study of Substance Abuse, sponsored by Brown University.

Completed
Registry status
NA
Development phase
340
Enrollment target
1
Study location

NCT00807742 is a NA study of Substance Abuse that has completed, run by Brown University. The registered enrollment target is 340 participants, below the 5,254-participant average among 58 other Substance Abuse trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00807742, a NA study of Substance Abuse, has completed, sponsored by Brown University.

COMPLETED
Registry status
NA
Development phase
340 participants
Enrollment target
1
Study location

Study Summary

The aim of this study is to determine whether contingent reinforcement for smoking abstinence, compared to noncontingent reinforcement, increases the effectiveness of brief counseling and nicotine replacement on smoking abstinence of substance abusers in residential treatment.

Conditions Studied

Interventions

  • BEHAVIORAL Contingency Management
  • BEHAVIORAL Brief Advice
  • DRUG Nicotine Replacement Treatment (NRT)
  • BEHAVIORAL Non-Contingent Reinforcement

Study Locations (1)

Rhode Island

  • Brown University, Center for Alcohol and Addiction Studies - Providence

Trial Details

FieldValue
Enrollment Target 340 participants
Start Date 2008-10
Est. Completion 2014-04
Phase NA

Sponsor

Brown University

231 total trials

What the Registry Record Tells You About NCT00807742

The ClinicalTrials.gov registry entry for NCT00807742 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 340 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,254-participant average among 58 other Substance Abuse trials with a reported enrollment target (94% lower). The listed sponsor is Brown University, which has 231 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Substance Abuse appearing as the primary indexed condition, and to 4 interventions - of which Contingency Management is the first listed.

NCT00807742 reports 1 study location spanning 1 distinct geographic area - top geographies include Rhode Island.

Frequently Asked Questions

What is clinical trial NCT00807742 about?

NCT00807742 is a clinical study titled "Contingency Management for Smoking in Substance Abusers". The aim of this study is to determine whether contingent reinforcement for smoking abstinence, compared to noncontingent reinforcement, increases the effectiveness of brief counseling and nicotine replacement on smoking abstinence of substance abusers in residential treatment.

What is the current status of trial NCT00807742?

This trial is currently completed. It is a NA study. The enrollment target is 340 participants. The study started on 2008-10. Estimated completion is 2014-04.

What conditions does trial NCT00807742 study?

This clinical trial studies the following conditions: Substance Abuse.

What interventions are being tested in trial NCT00807742?

The interventions under investigation include: Contingency Management (BEHAVIORAL), Brief Advice (BEHAVIORAL), Nicotine Replacement Treatment (NRT) (DRUG), Non-Contingent Reinforcement (BEHAVIORAL).

Who is sponsoring clinical trial NCT00807742?

This trial is sponsored by Brown University, which has 231 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00807742 being conducted?

This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Substance Abuse

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.